CD4 and AIDS: In our study, for patients with HIV/AIDS who had a baseline CD4+ T-cell count of <350 cells/mL, and especially for patients with HIV/AIDS who had a baseline CD4+ T-cell count of <200 cells/mL, treatment with TCM plus cART increased the CD4+ T-cell count to 350 cells/mL more rapidly compared with treatment with cART alone; however, the difference between treatment groups disappeared once the CD4+ T-cell count reached approximately 350 cells/mL.